BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9169829)

  • 1. Impact of differences in ultrasound and computed tomography volumes on treatment planning of permanent prostate implants.
    Narayana V; Roberson PL; Pu AT; Sandler H; Winfield RH; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1181-5. PubMed ID: 9169829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ultrasound and computed tomography prostate volume registration on evaluation of permanent prostate implants.
    Narayana V; Roberson PL; Winfield RJ; McLaughlin PW
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):341-6. PubMed ID: 9308937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
    Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of MRI pulse sequences in defining prostate volume after permanent implantation.
    McLaughlin PW; Narayana V; Drake DG; Miller BM; Marsh L; Chan J; Gonda R; Winfield RJ; Roberson PL
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):703-11. PubMed ID: 12377321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between pre- and postimplant dosimetry for iodine-125 seed implants for localized prostate cancer.
    Al-Qaisieh B; Witteveen T; Carey B; Henry A; Bottomley D; Smith J; Franks K; Bownes P
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):626-30. PubMed ID: 19540077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prostatic edema on CT-based postimplant dosimetry.
    Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
    Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy.
    Stone NN; Hong S; Lo YC; Howard V; Stock RG
    Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of edema associated with 131Cs prostate permanent seed implants on dosimetric quality indices.
    Kehwar TS; Jones HA; Huq MS; Beriwal S; Benoit RM; Smith RP
    Med Phys; 2009 Aug; 36(8):3536-42. PubMed ID: 19746787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
    Yue N; Dicker AP; Corn BW; Nath R; Waterman FM
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):447-54. PubMed ID: 10030274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brachytherapy in patients with small prostate glands.
    Loblaw DA; Wallner K; Dibiase S; Russell K; Blasko J; Ellis W
    Tech Urol; 2000 Jun; 6(2):64-9. PubMed ID: 10798802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
    Yue N; Chen Z; Peschel R; Dicker AP; Waterman FM; Nath R
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1063-72. PubMed ID: 10571216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of intraoperative ultrasound with postimplant computed tomography--dosimetric values at Day 1 and Day 30 after prostate brachytherapy.
    Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M; Shigematsu N; Kubo A
    Brachytherapy; 2007; 6(4):246-53. PubMed ID: 17959425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preimplant factors affecting postimplant CT-determined prostate volume and the CT/TRUS volume ratio after transperineal interstitial prostate brachytherapy with 125I free seeds.
    Sugawara A; Nakashima J; Kunieda E; Nagata H; Asakura H; Oya M; Shigematsu N
    Radiat Oncol; 2010 Sep; 5():86. PubMed ID: 20875137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of interobserver variability on transrectal ultrasonography-based postimplant dosimetry.
    Xue J; Waterman F; Handler J; Gressen E
    Brachytherapy; 2006; 5(3):174-82. PubMed ID: 16864069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sector analysis of dosimetry of prostate cancer patients treated with low-dose-rate brachytherapy.
    Nasser NJ; Wang Y; Borg J; Saibishkumar EP
    Brachytherapy; 2014; 13(4):369-74. PubMed ID: 24559795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-CT fusion compared with MR-CT fusion for postimplant dosimetry in permanent prostate brachytherapy.
    Bowes D; Crook JM; Araujo C; Batchelar D
    Brachytherapy; 2013; 12(1):38-43. PubMed ID: 22727473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the relationship between pre- and postimplant geometry in prostate low-dose-rate brachytherapy and its correlation with dosimetric quality using the similarity concept.
    Todor DA; Anscher MS; Karlin JD; Hagan MP
    Brachytherapy; 2014; 13(5):471-80. PubMed ID: 25037911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of real-time intraoperative ultrasound-based dosimetry with postoperative computed tomography-based dosimetry for prostate brachytherapy.
    Nag S; Shi P; Liu B; Gupta N; Bahnson RR; Wang JZ
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):311-7. PubMed ID: 17996395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Source placement error for permanent implant of the prostate.
    Roberson PL; Narayana V; McShan DL; Winfield RJ; McLaughlin PW
    Med Phys; 1997 Feb; 24(2):251-7. PubMed ID: 9048365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of transrectal ultrasound- and computed tomography-based seed localization on postimplant dosimetry in prostate brachytherapy.
    Chew MS; Xue J; Houser C; Misic V; Cao J; Cornwell T; Handler J; Yu Y; Gressen E
    Brachytherapy; 2009; 8(2):255-264. PubMed ID: 19213606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.